Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
300760
주식 순위
#785
Operating on a global scale, Shenzhen Mindray Bio-Medical Electronics Co., Ltd.... Operating on a global scale, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. specializes in providing a comprehensive range of medical devices and innovative healthcare solutions. Its extensive portfolio encompasses several key segments. Within patient monitoring and life support, the company manufactures crucial equipment such as patient monitoring systems, electrocardiographs, defibrillators, anesthesia machines, ventilators, infusion pumps, surgical lights, operating tables, medical supply units, and endoscopes, along with associated accessories. This segment also delivers integrated solutions for emergency care, peri-operative management, critical care, and medical IT systems. For in-vitro diagnostics, Mindray offers sophisticated products including hematology and chemistry analyzers and their reagents, chemiluminescence immunoassay products, hemoglobin systems, flow cytometry instruments, and microplate readers and washers. These are further supported by solutions tailored for coagulation, urinalysis, and microbiology. The company additionally produces advanced medical imaging systems, covering both ultrasound and radiology products, and supplies a dedicated line of veterinary products. Founded in 1991, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. maintains its primary operational base in Shenzhen, People's Republic of China.
주가
$25.47
마지막 동기화: 2026-10-21
시가총액
$30.86B
변동 (1일)
3.53%
변동 (1년)
-17.57%
국가
CN
거래 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760)
카테고리
Healthcare
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760)의 매출
Jun 2026 기준 매출 TTM: $4.94B
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $4.94B입니다. 2023년에 회사는 $4.93B의 수익을 올렸으며 이는 2022년의 $4.40B 대비 증가입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.의 수익 기록 (2014 ~ 2026)
매년 말 매출
| 연도 | 매출 | 변화 |
|---|---|---|
| 2026 (TTM) | $4.94B | -1.85% |
| 2024 | $5.03B | 1.96% |
| 2023 | $4.93B | 12.10% |
| 2022 | $4.40B | 10.72% |
| 2021 | $3.98B | 23.53% |
| 2020 | $3.22B | 35.37% |
| 2019 | $2.38B | 18.91% |
| 2018 | $2.00B | 16.42% |
| 2017 | $1.72B | 32.02% |
| 2016 | $1.30B | 5.42% |
| 2015 | $1.23B | -2.46% |
| 2014 | $1.27B | 0.00% |
유사 기업 또는 경쟁사의 매출
| 회사 | 매출 | 매출 차이 | 국가 |
|---|---|---|---|
| $46.59B | 843.34% |
US
|
|
| $35.48B | 618.54% |
IE
|
|
| $25.84B | 423.19% |
US
|
|
| $21.00B | 325.16% |
US
|
|
| - | - |
DE
|
